|
|
|
Insider
Information: |
Freund John Gordon |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
11 |
|
Direct
Shares |
2,264,960 |
|
Indirect Shares
|
9,013,510 |
|
|
Direct
Value |
$6,212,402 |
|
|
Indirect Value
|
$18,521,673 |
|
|
Total
Shares |
11,278,470 |
|
|
Total
Value |
$24,734,076 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Xenoport Inc |
XNPT |
Director |
2016-07-05 |
0 |
2016-07-05 |
0 |
Premium* |
|
Hansen Medical Inc |
HNSN |
Director |
2006-11-21 |
0 |
2009-04-17 |
2,000,936 |
Premium* |
|
Map Pharmaceuticals Inc |
MAPP |
Director, 10% Owner |
2011-02-14 |
1,984 |
2011-05-20 |
5,152 |
Premium* |
|
Mako Surgical Corp. |
MAKO |
Director |
|
0 |
2013-12-17 |
0 |
Premium* |
|
Acelrx Pharmaceuticals Inc |
ACRX |
10% Owner |
2011-02-16 |
0 |
2012-05-29 |
4,161,933 |
Premium* |
|
Tetraphase Pharmaceuticals Inc |
TTPH |
Director |
2019-12-10 |
0 |
2019-12-10 |
0 |
Premium* |
|
Concert Pharmaceuticals, Inc. |
CNCE |
Director, 10% Owner |
|
0 |
2014-02-20 |
1,208,920 |
Premium* |
|
Protara Therapeutics, Inc |
TARA |
Director |
2019-11-08 |
2,175,882 |
2014-10-27 |
1,432,930 |
Premium* |
|
Collegium Pharmaceutical, Inc |
COLL |
Director |
2024-05-16 |
52,468 |
2024-05-16 |
43,413 |
Premium* |
|
Sutro Biopharma Inc |
STRO |
Director |
2018-10-01 |
0 |
2020-12-10 |
56,327 |
Premium* |
|
Si-Bone, Inc. |
SIBN |
|
2024-06-26 |
34,626 |
2024-06-26 |
103,899 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
142 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MAPP |
Map Pharmaceuticals Inc |
Director |
|
2007-10-11 |
4 |
A |
$14.50 |
$1,868,757 |
I/I |
128,862 |
212,195 |
0 |
- |
|
SIBN |
Si-Bone, Inc. |
Director |
|
2018-10-19 |
4 |
B |
$15.00 |
$4,875,000 |
I/I |
325,000 |
4,419,985 |
2.25 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2014-09-05 |
4 |
AS |
$15.01 |
$183,532 |
I/I |
(12,227) |
1,494,619 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2014-09-08 |
4 |
AS |
$15.01 |
$67,126 |
I/I |
(4,473) |
1,490,146 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2014-09-03 |
4 |
AS |
$15.04 |
$2,137,241 |
I/I |
(142,100) |
1,548,046 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2014-09-04 |
4 |
AS |
$15.06 |
$620,596 |
I/I |
(41,200) |
1,506,846 |
0 |
- |
|
XNPT |
Xenoport Inc |
Director |
|
2005-09-13 |
4 |
B |
$15.07 |
$63,524 |
I/I |
4,200 |
1,110,559 |
2.1 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2014-09-11 |
4 |
AS |
$17.00 |
$35,708 |
I/I |
(2,100) |
1,488,046 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2014-09-12 |
4 |
AS |
$17.01 |
$910,757 |
I/I |
(53,544) |
1,434,502 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2014-09-16 |
4 |
AS |
$17.03 |
$1,147,140 |
I/I |
(67,356) |
1,367,146 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2014-09-17 |
4 |
AS |
$17.36 |
$1,336,597 |
I/I |
(77,000) |
1,290,146 |
0 |
- |
|
SIBN |
Si-Bone, Inc. |
|
|
2019-08-12 |
4 |
S |
$18.25 |
$7,300,000 |
I/I |
(400,000) |
4,019,985 |
0 |
- |
|
SIBN |
Si-Bone, Inc. |
|
|
2019-08-26 |
4 |
S |
$18.40 |
$2,805,181 |
I/I |
(152,424) |
3,819,985 |
0 |
- |
|
XNPT |
Xenoport Inc |
Director |
|
2009-07-10 |
4 |
B |
$18.95 |
$95,081 |
I/I |
5,000 |
6,200 |
2.1 |
- |
|
XNPT |
Xenoport Inc |
Director |
|
2009-07-08 |
4 |
B |
$19.00 |
$2,470,000 |
I/I |
130,000 |
1,188,257 |
2.1 |
- |
|
SIBN |
Si-Bone, Inc. |
|
|
2019-08-23 |
4 |
S |
$20.03 |
$3,605 |
I/I |
(180) |
3,972,409 |
0 |
- |
|
SIBN |
Si-Bone, Inc. |
|
|
2019-08-22 |
4 |
S |
$20.05 |
$43,807 |
I/I |
(2,185) |
3,972,589 |
0 |
- |
|
SIBN |
Si-Bone, Inc. |
|
|
2019-08-21 |
4 |
S |
$20.14 |
$911,057 |
I/I |
(45,211) |
3,974,774 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2014-09-30 |
4 |
AS |
$20.17 |
$1,141,844 |
I/I |
(56,618) |
1,137,880 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2014-09-29 |
4 |
AS |
$20.19 |
$1,931,334 |
I/I |
(95,648) |
1,194,498 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2014-10-01 |
4 |
AS |
$20.41 |
$2,962,731 |
I/I |
(142,146) |
995,734 |
0 |
- |
|
SIBN |
Si-Bone, Inc. |
|
|
2023-08-09 |
4 |
S |
$20.54 |
$616,197 |
I/I |
(30,000) |
103,899 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2014-10-02 |
4 |
AS |
$20.72 |
$2,211,146 |
I/I |
(105,588) |
890,146 |
0 |
- |
|
SIBN |
Si-Bone, Inc. |
|
|
2020-10-19 |
4 |
S |
$22.00 |
$4,181,166 |
I/I |
(190,053) |
2,129,932 |
0 |
- |
|
SIBN |
Si-Bone, Inc. |
|
|
2020-12-02 |
4 |
S |
$23.28 |
$2,328,480 |
I/I |
(100,000) |
1,529,932 |
0 |
- |
|
142 Records found
|
|
Page 5 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|